Opsens (TSX:OPS) Debt-to-Revenue : 0.16 (As of Aug. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Opsens Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Opsens's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$0.99 Mil. Opsens's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was C$8.22 Mil. Opsens's annualized Revenue for the quarter that ended in Aug. 2023 was C$56.76 Mil. Opsens's annualized Debt-to-Revenue for the quarter that ended in Aug. 2023 was 0.16.

Opsens Debt-to-Revenue Historical Data

The historical data trend for Opsens's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens Debt-to-Revenue Chart

Opsens Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Debt-to-Revenue

Get a 7-Day Free Trial

0.23

0.44

0.35

0.19

Opsens Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Debt-to-Revenue	Get a 7-Day Free Trial															0.19	0.25	0.23	0.20	0.16

Competitive Comparison of Opsens's Debt-to-Revenue

For the Medical Instruments & Supplies subindustry, Opsens's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opsens's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Opsens's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Opsens's Debt-to-Revenue falls into.

Opsens Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Opsens's Debt-to-Revenue for the fiscal year that ended in Aug. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.987	+	8.221)	/	48.347
	=	0.19

Opsens's annualized Debt-to-Revenue for the quarter that ended in Aug. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.987	+	8.221)	/	56.76
	=	0.16

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Aug. 2023) Revenue data.

Opsens Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Opsens's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Opsens (TSX:OPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3

Website

https://www.opsens.com

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.

Executives

Alan Milinazzo	Director
Robin Villeneuve	Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.)	10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines